🔎 Trials Near Me

Home › Chronic Lymphocytic Leukemia › Utah

Chronic Lymphocytic Leukemia clinical trials in Utah

10 studies for Chronic Lymphocytic Leukemia are looking for participants at sites in Utah.

Cities in Utah

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

  • Huntsman Cancer Institute/University of Utah, Salt Lake City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT04269902

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

  • Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07277231

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

  • University of Utah, Salt Lake City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07221500

Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia

  • Huntsman Cancer Institute/University of Utah, Salt Lake City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT07061951

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

  • Huntsman Cancer Institute at The University of Utah, Salt Lake City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05091424

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

  • University of Utah, Salt Lake City
RecruitingPhase 1
Ages 13 and older · All sexes · Updated May 5, 2026 · NCT04771572

Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial

  • Huntsman Cancer Institute/University of Utah, Salt Lake City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 9, 2026 · NCT05183854

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

  • Huntsman Cancer Institute, University of Utah, Salt Lake City
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Mar 20, 2026 · NCT04830137

Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers

  • Huntsman Cancer Institute at University of Utah, Salt Lake City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 3, 2025 · NCT04844528

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

  • University of Utah, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 14, 2025 · NCT05643742

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.